Cart
sales@molnova.com
ecMetAP-IN-1
CAS No. 7471-12-7
ecMetAP-IN-1( —— )
Catalog No. M35307 CAS No. 7471-12-7
ecMetAP-IN-1 can be used as a QSAR model to study methionine aminopeptidase inhibitor as an anticancer agent using multiple linear regression.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 39 | Get Quote |
|
| 10MG | 54 | Get Quote |
|
| 25MG | 82 | Get Quote |
|
| 50MG | 121 | Get Quote |
|
| 100MG | 172 | Get Quote |
|
| 200MG | 255 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameecMetAP-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionecMetAP-IN-1 can be used as a QSAR model to study methionine aminopeptidase inhibitor as an anticancer agent using multiple linear regression.
-
DescriptionecMetAP-IN-1 (compound 17) is a potent ecMetAP inhibitor with an IC50 value of 2.086 μM.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number7471-12-7
-
Formula Weight209.25
-
Molecular FormulaC13H11N3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC=1C=C2N=C(NC2=CC1)C3=CC=CC=N3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Schiffmann R, et al. Metal-mediated inhibition of Escherichia coli methionine aminopeptidase: structure-activity relationships and development of a novel scoring function for metal-ligand interactions. J Med Chem. 2006 Jan 26;49(2):511-22.?
molnova catalog
related products
-
FA-alkyne
FA-alkyne (FA alkyne) is a fluorescein that is a competitive probe for natural S-succinylation in FH-/- and FH+/+ cells and can be used to synthesize nanophotosensors.
-
2,6-Dihydroxypurine
A purine base found in most body tissues and fluids, certain plants, and some urinary calculi.
-
Euchrestaflavanone B
Euchrestaflavanone B shows antibacterial activity against Gram positive bacteria, Staphylococcus aureus, Bacillus subtilis and Bacillus cereus. Euchrestaflavanone B may function by inhibiting oncogenic disease, at least in part, through the inhibition of protein kinase CKII activity.
